Eli Lilly says monoclonal antibody cocktail cuts hospitalizations by 70% for high-risk COVID-19 patients
Among high-risk patients who received a placebo, 10% were hospitalized, compared to just 2% of those who received the drug cocktail -- a 70% drop. |!| Marco Island
